Sandra A. Gardiner - Apr 17, 2023 Form 3 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role: Chief Financial Officer
Signature: Mark A. Wilson, Attorney-in-Fact
Stock symbol: NKTR
Transactions as of: Apr 17, 2023
Transactions value $: $0
Form type: 3
Date filed: 4/25/2023, 09:03 PM
Previous filing: Apr 4, 2023
Next filing: Sep 18, 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Ex-24 Power of Attorney